The Manitoba human papillomavirus vaccine surveillance and evaluation system.

Erich V. Kliewer*, Alain A. Demers, Marc Brisson, Alberto Severini, Robert Lotocki, Brenda Elias, Gregory Hammond, George Wurtak, HPV Research Group Manitoba HPV Research Group

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Abstract

BACKGROUND: With the recent introduction of a human papillomavirus (HPV) vaccine in Canada, it is important to establish surveillance and evaluation programs that not only track the uptake of the vaccine, but also assess its safety and its impact on: distribution of HPV type, cervical cancer screening programs, the incidence of anogenital warts, precancerous lesions and various cancers, and sexual behaviour. DATA SOURCES AND METHODS: Administrative databases, registries and questionnaire information are being linked to identify people receiving the HPV vaccine and to develop an evaluation system. INTERPRETATION: The availability of extensive linkable databases in Manitoba allows for the development of a comprehensive HPV vaccine surveillance and evaluation system that can address many of the questions related to the HPV vaccine. Aspects of the Manitoba surveillance and evaluation system could be implemented in other provinces that have similar databases.

Original languageEnglish
Pages (from-to)37-42
Number of pages6
JournalHealth Reports
Volume21
Issue number2
Publication statusPublished - Jun 2010
Externally publishedYes

Fingerprint

Dive into the research topics of 'The Manitoba human papillomavirus vaccine surveillance and evaluation system.'. Together they form a unique fingerprint.

Cite this